Clinicopathological features of clinically undiagnosed sporadic transthyretin cardiac amyloidosis: a forensic autopsy-based series

References

• Wechalekar AD, Gillmore JD, Hawkins PN. Systemic amyloidosis. Lancet. 2016;387(10038):2641–2654.
   PubMed Web of Science ®Google Scholar
• Benson MD, Buxbaum JN, Eisenberg DS, et al. Amyloid nomenclature 2020: update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee. Amyloid. 2020;27(4):217–222.
   PubMed Web of Science ®Google Scholar
• Nishida N, Yoshida K, Hata Y, et al. Pathological features of preclinical or early clinical stages of corticobasal degeneration: a comparison with advanced cases. Neuropathol Appl Neurobiol. 2015;41(7):893–905.
   PubMed Web of Science ®Google Scholar
• Yoshida K, Hata Y, Kinoshita K, et al. Incipient progressive supranuclear palsy is more common than expected and may comprise clinicopathological subtypes: a forensic autopsy series. Acta Neuropathol. 2017;133(5):809–823.
   PubMed Web of Science ®Google Scholar
• Sekijima Y, Yazaki M, Ueda M, et al. First nationwide survey on systemic wild-type ATTR amyloidosis in Japan. Amyloid. 2018;25(1):8–10.
   PubMed Web of Science ®Google Scholar
• Mints YY, Doros G, Berk JL, et al. Features of atrial fibrillation in wild-type transthyretin cardiac amyloidosis: a systematic review and clinical experience. ESC Heart Fail. 2018;5(5):772–779.
   PubMed Web of Science ®Google Scholar
• Grogan M, Scott CG, Kyle RA, et al. Natural history of wild-type transthyretin cardiac amyloidosis and risk stratification using a novel staging system. J Am Coll Cardiol. 2016;68(10):1014–1020.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Lopez E, Gagliardi C, Dominguez F, et al. Clinical characteristics of wild-type transthyretin cardiac amyloidosis: disproving myths. Eur Heart J. 2017;38(24):1895–1904.
   PubMed Web of Science ®Google Scholar
• Sanchis K, Cariou E, Colombat M, et al. Atrial fibrillation and subtype of atrial fibrillation in cardiac amyloidosis: clinical and echocardiographic features, impact on mortality. Amyloid. 2019;26(3):128–138.
   PubMed Web of Science ®Google Scholar
• Longhi S, Quarta CC, Milandri A, et al. Atrial fibrillation in amyloidotic cardiomyopathy: prevalence, incidence, risk factors and prognostic role. Amyloid. 2015;22(3):147–155.
   PubMed Web of Science ®Google Scholar
• Kawamura S, Takahashi M, Ishihara T, et al. Incidence and distribution of isolated atrial amyloid: histologic and immunohistochemical studies of 100 aging hearts. Pathol Int. 1995;45(5):335–342.
   PubMed Web of Science ®Google Scholar
• Steiner I. The prevalence of isolated atrial amyloid. J Pathol. 1987;153(4):395–398.
   PubMed Web of Science ®Google Scholar
• Röcken C, Peters B, Juenemann G, et al. Atrial amyloidosis: an arrhythmogenic substrate for persistent atrial fibrillation. Circulation. 2002;106(16):2091–2097.
   PubMed Web of Science ®Google Scholar
• Park J, Lee SH, Lee JS, et al. High recurrence of atrial fibrillation in patients with high tissue atrial natriuretic peptide and amyloid levels after concomitant maze and mitral valve surgery. J Cardiol. 2017;69(1):345–352.
   PubMed Web of Science ®Google Scholar
• Ridolfi RL, Bulkley BH, Hutchins GM. The conduction system in cardiac amyloidosis. Clinical and pathologic features of 23 patients. Am J Med. 1977;62(5):677–686.
   PubMed Web of Science ®Google Scholar
• Larsson A, Malmstrom S, Westermark P. Signs of cross-seeding: aortic medin amyloid as a trigger for protein AA deposition. Amyloid. 2011;18(4):229–234.
   PubMed Web of Science ®Google Scholar
• Hitosugi M, Takatsu A, Kinugasa Y, et al. Estimation of normal heart weight in Japanese subjects: development of a simplified normal heart weight scale. Leg Med (Tokyo). 1999;1(2):80–85.
   PubMedGoogle Scholar
• Hata Y, Hirono K, Yamaguchi Y, et al. Minimal inflammatory foci of unknown etiology may be a tentative sign of early stage inherited cardiomyopathy. Mod Pathol. 2019;32(9):1281–1290.
   PubMed Web of Science ®Google Scholar
• Hoshii YI. Typing of amyloidosis. Pathol Clin Med. 2016;34(5):481–485.
   Google Scholar
• Hoshii Y, Nanbara H, Cui D, et al. Immunohistochemical examination of Aκ amyloidosis with antibody against adjacent portion of the carboxy terminus of immunoglobulin kappa light chain. Med Mol Morphol. 2012;45(3):124–128.
   PubMed Web of Science ®Google Scholar
• Larsen BT, Mereuta OM, Dasari S, et al. Correlation of histomorphological pattern of cardiac amyloid deposition with amyloid type: a histological and proteomic analysis of 108 cases. Histopathology. 2016;68(5):648–656.
   PubMed Web of Science ®Google Scholar
• Ichimata S, Kobayashi M, Shimojo H, et al. Usefulness of gastroduodenal biopsy in the differential diagnosis of systemic AH amyloidosis from systemic AL amyloidosis. Histopathology. 2018;73(2):230–239.
   PubMed Web of Science ®Google Scholar
• Shiozaki T, Sato N, Hayashi T, et al. Wild-type ATTR amyloidosis may be associated with unexpected death among the elderly. Leg Med (Tokyo). 2019;41:101634.
   PubMed Web of Science ®Google Scholar
• Ueda M, Horibata Y, Shono M, et al. Clinicopathological features of senile systemic amyloidosis: an ante- and post-mortem study. Mod Pathol. 2011;24(12):1533–1544.
   PubMed Web of Science ®Google Scholar
• Falk RH. Senile systemic amyloidosis: are regional differences real or do they reflect different diagnostic suspicion and use of techniques? Amyloid. 2012;19:68–70.
   PubMed Web of Science ®Google Scholar
• Tanskanen M, Peuralinna T, Polvikoski T, et al. Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation in alpha2-macroglobulin and tau: a population-based autopsy study. Ann Med. 2008;40(3):232–239.
   PubMed Web of Science ®Google Scholar
• Cornwell GG, Murdoch WL, Kyle RA, et al. Frequency and distribution of senile cardiovascular amyloid. A clinicopathologic correlation. Am J Med. 1983;75(4):618–623.
   PubMed Web of Science ®Google Scholar
• Hata Y, Ichimata S, Yamaguchi Y, et al. Clinicopathological and genetic profiles of cases with myocytes disarray-investigation for establishing the autopsy diagnostic criteria for hypertrophic cardiomyopathy. J Clin Med. 2019;8(4):463.
   Web of Science ®Google Scholar
• Dorbala S, Ando Y, Bokhari S, et al. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 1 of 2-evidence base and standardized methods of imaging. J Card Fail. 2019;25(11):e1–e39.
   PubMed Web of Science ®Google Scholar
• Dorbala S, Ando Y, Bokhari S, et al. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 2 of 2-diagnostic criteria and appropriate utilization. J Card Fail. 2019;25(11):854–865.
   PubMed Web of Science ®Google Scholar
• Cheung CC, Roston TM, Andrade JG, et al. Arrhythmias in cardiac amyloidosis: challenges in risk stratification and treatment. Can J Cardiol. 2020;36(3):416–423.
   PubMed Web of Science ®Google Scholar
• Barra SN, Providencia R, Paiva L, et al. A review on advanced atrioventricular block in young or middle-aged adults. Pacing Clin Electrophysiol. 2012;35(11):1395–1405.
   PubMed Web of Science ®Google Scholar
• Phelan D, Collier P, Thavendiranathan P, et al. Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis. Heart. 2012;98(19):1442–1448.
   PubMed Web of Science ®Google Scholar
• Quarta CC, Gonzalez-Lopez E, Gilbertson JA, et al. Diagnostic sensitivity of abdominal fat aspiration in cardiac amyloidosis. Eur Heart J. 2017;38(24):1905–1908.
   PubMed Web of Science ®Google Scholar
• Yamashita T, Ueda M, Misumi Y, et al. Genetic and clinical characteristics of hereditary transthyretin amyloidosis in endemic and non-endemic areas: experience from a single-referral center in Japan. J Neurol. 2018;265(1):134–140.
   PubMed Web of Science ®Google Scholar
• Naiki H, Sekijima Y, Ueda M, et al. Human amyloidosis, still intractable but becoming curable: The essential role of pathological diagnosis in the selection of type-specific therapeutics. Pathol Int. 2020;70(4):191–198.
   PubMed Web of Science ®Google Scholar